V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270009495 | 270005627 | 1.62 | 64.6 | Palliative (P) | 2013-09-10 | 2013-09-11 | Cetuximab + Oxaliplatin + MdG Load | N | N | 270018848 | BEVACIZUMAB + IRINOTECAN + MdG |
| 270009496 | 270005628 | 0 | 74 | Palliative (P) | 2018-01-05 | 2018-01-18 | Bevacizumab 5mg/kg | 02 | Y | 270018849 | CETUXIMAB + OXALIPLATIN + MDG |
| 270009497 | 270005629 | 1.85 | 80.9 | Curative (C) | 2016-08-16 | 2016-09-17 | Carboplatin + Vinorelbine Oral | null | null | 270018850 | CARBO + FLUOROURACIL |
| 270009498 | 270005630 | 1.59 | 63 | Adjuvant (A) | 2014-10-22 | 2014-10-22 | Bevacizumab + Irinotecan + MdG | 02 | N | 270018855 | CETUXIMAB |
| 270009499 | 270005631 | 1.55 | 46 | Curative (C) | 2013-06-18 | 2013-07-13 | CAPECITABINE + MITOMYCIN + RT | N | N | 270018856 | CAPECITABINE + MITOMYCIN + RT |
| 270009500 | 270005632 | 0 | 73.4 | Curative (C) | 2014-08-15 | 2014-08-29 | GEMCARBO | N | Y | 270018858 | CARBOPLATIN |
| 270009501 | 270005633 | 1.62 | 84.2 | Curative (C) | 2016-06-10 | 2016-06-11 | Bevacizumab | N | N | 270018860 | CARBOPLATIN |
| 270009502 | 270005634 | 1.8 | 78.9 | Curative (C) | 2017-12-22 | 2017-12-29 | CAP + RT | 02 | N | 270018867 | CARBOPLATIN + RT |
| 270009503 | 270005635 | 1.72 | 79.9 | Palliative (P) | 2016-02-25 | 2016-02-26 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | 270018869 | CETUXIMAB |
| 270009504 | 270005636 | 1.7 | 73 | Neo-adjuvant (N) | 2017-02-03 | 2017-02-25 | Enzalutamide | 2 | Y | 270018871 | CARBOPLATIN + RT |
| 270009505 | 270005636 | null | null | Curative (C) | null | 2014-02-03 | Bevacizumab + Cape + Oxali 14day | null | null | 270018871 | CETUXIMAB |
| 270009506 | 270005637 | 1.67 | 75.4 | Palliative (P) | 2014-12-19 | 2014-12-31 | CETUXIMAB + OXALIPLATIN + MDG | N | Y | 270018889 | BEVACIZUMAB |
| 270009507 | 270005638 | null | 89.7 | Palliative (P) | 2015-05-23 | 2015-06-02 | CISPLATIN + VINORELBINE | 2 | N | 270018894 | CARBOPLATIN + RT |
| 270009508 | 270005639 | null | 53 | Palliative (P) | 2016-04-03 | 2016-04-07 | Cetuximab + FOLFIRI cycle 2 onwards | N | null | 270018897 | IRINOTECAN |
| 270009510 | 270005641 | 1.71 | 102 | Palliative (P) | 2014-06-28 | 2014-07-23 | Capecitabine (14 day) + Irinotecan | 02 | N | 270018916 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 270009511 | 270005642 | 1.6 | 58.4 | Curative (C) | 2015-07-01 | 2015-07-01 | CETUXIMAB + RT | 2 | N | 270018933 | CISPLATIN + ETOPOSIDE |
| 270009512 | 270005643 | 1.67 | 73.3 | Not known (9) | 2013-04-18 | 2013-04-18 | SCOT TRIAL | 2 | N | 270018940 | ECX |
| 270009513 | 270005643 | 1.49 | 61 | Palliative (P) | 2016-07-15 | 2016-07-19 | CARBOPLATIN + FLUOROURACIL | 02 | N | 270018940 | DOCETAXEL |
| 270009514 | 270005643 | 1.54 | 73.9 | Palliative (P) | 2017-10-15 | 2017-10-21 | Bevacizumab + Cape + Oxali 21day | 02 | N | 270018940 | CARBOPLATIN + PEMETREXED |
| 270009515 | 270005643 | 1.62 | 49.8 | Palliative (P) | null | 2013-02-09 | CAPECITABINE + IRINOTECAN | null | null | 270018940 | BEVACIZUMAB + CAPE + IRINOTECAN |
| 270009517 | 270005644 | 1.83 | 100 | Curative (C) | 2015-10-30 | 2015-11-07 | Cetuximab + FLUOROURACIL + FOLINIC ACID + OXALIPLATIN | N | N | 270018988 | CETUXIMAB + MDG |
| 270009519 | 270016008 | null | 54 | null | 2013-03-10 | 2013-04-07 | Chlorambucil | N | N | 270018999 | BENDAMUSTINE + RITUXIMAB |
| 270009520 | 270005645 | 1.71 | null | Palliative (P) | null | 2014-06-27 | Carboplatin AUC 6 - 10 | N | null | 270019004 | CISPLATIN + ETOPOSIDE |
| 270009521 | 270005645 | 1.65 | 67 | Palliative (P) | 2014-04-21 | 2014-04-28 | Brentuximab | 02 | N | 270019004 | BRENTUXIMAB |
| 270009522 | 270005645 | null | null | Neo-adjuvant (N) | 2015-03-26 | 2015-03-26 | Cetuximab + FOLFIRI cycle1 | null | null | 270019004 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 270009524 | 270005647 | 1.82 | 89.9 | Palliative (P) | 2013-10-02 | 2013-10-02 | Enzalutamide | Y | N | 270019028 | CETUXIMAB + RT |
| 270009525 | 270005648 | null | 83.2 | Palliative (P) | 2015-10-01 | 2015-10-06 | Fluorouracil + Folinic + RT Bossett | N | N | 270019030 | CARBOPLATIN + RT |
| 270009526 | 270005649 | null | 103 | Palliative (P) | 2016-02-17 | 2016-02-17 | Carboplatin AUC 2 - 5 | Y | N | 270019031 | FLUOROURACIL + RT |
| 270009527 | 270005649 | 1.56 | 65 | Adjuvant (A) | 2016-09-07 | 2016-08-30 | Mitomycin Intravesical | N | N | 270019031 | CARBOPLATIN + RT |
| 270009528 | 270005650 | 1.65 | 78.1 | null | 2017-06-14 | 2017-08-05 | Cisplatin + Vinorelbine (IV) | N | N | 270019061 | DOCETAXEL |
| 270009529 | 270005651 | 1.69 | 78 | Palliative (P) | 2014-06-07 | 2014-06-17 | Trifluridine + Tipiracil | N | N | 270019069 | CHOP |
| 270009530 | 270012790 | null | 51.6 | Palliative (P) | 2016-10-30 | 2016-11-18 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | 270019075 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270009531 | 270012790 | 1.75 | 79.4 | Palliative (P) | 2016-07-17 | 2016-08-02 | CAP + RT | N | N | 270019075 | CARBOPLATIN + ETOPOSIDE |
| 270009532 | 270005652 | 1.71 | 52.3 | Palliative (P) | 2014-04-19 | 2014-04-20 | Irinotecan | 02 | N | 270019099 | CETUXIMAB + IRINOTECAN + MDG |
| 270009533 | 270005652 | null | null | null | 2012-01-20 | 2013-06-19 | CETUXIMAB + RT | N | N | 270019099 | CARBOPLATIN |
| 270009534 | 270005653 | 1.73 | 62.5 | Curative (C) | 2016-09-03 | 2016-09-08 | Carboplatin+Fluorouracil 4 or 5 day | null | N | 270019111 | SCOT TRIAL |
| 270009535 | 270005654 | 1.61 | 83.5 | null | 2015-04-11 | 2015-04-11 | Carboplatin AUC 2 - 5 | N | N | 270019112 | CARBOPLATIN + RT |
| 270009536 | 270005655 | null | 74 | Adjuvant (A) | 2014-02-26 | 2014-03-21 | OXALIPLATIN | 02 | N | 270019120 | ENZALUTAMIDE |
| 270009537 | 270005656 | null | null | Adjuvant (A) | 2014-04-10 | 2014-04-25 | Bevacizumab + Cape + Oxali 21day | null | null | 270019121 | CETUXIMAB |
| 270009538 | 270005657 | 1.79 | 61.2 | Curative (C) | 2014-11-25 | 2014-11-25 | GEMCITABINE | N | N | 270019138 | FLUOROURACIL + RT |
| 270009539 | 270005658 | 1.67 | 65.2 | Palliative (P) | 2017-01-26 | 2017-02-01 | CARBOPLATIN + RT | 02 | N | 270019158 | CETUXIMAB + RT |
| 270009540 | 270005658 | 1.67 | 159 | Neo-adjuvant (N) | 2015-12-13 | 2015-12-14 | Cetuximab + FOLFIRI cycle1 | 02 | N | 270019158 | CETUXIMAB + IRINOTECAN + MDG |
| 270009541 | 270005659 | 1.65 | 64.2 | Adjuvant (A) | 2015-10-05 | 2015-11-16 | CARBOPLATIN + RT | N | N | 270019176 | CETUXIMAB + RT |
| 270009542 | 270005659 | 1.73 | 101 | Curative (C) | 2017-09-03 | 2017-09-10 | Cetuximab + Radiotherapy Load | 02 | N | 270019176 | CAP + RT |
| 270009543 | 270005660 | 1.78 | 136 | Curative (C) | 2013-06-29 | 2013-07-20 | CAP + RT | 02 | N | 270019193 | BEVACIZUMAB |
| 270009544 | 270005660 | 1.85 | 95 | Palliative (P) | 2016-10-31 | 2016-11-05 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | 270019193 | CETUXIMAB + IRINOTECAN + MDG |
| 270009545 | 270005661 | 1.72 | 70.6 | Curative (C) | 2014-10-13 | 2014-10-20 | Cetuximab 7 day (Cycle 1) | 02 | N | 270019205 | CAP + RT |
| 270009546 | 270005662 | 0 | 90.9 | Palliative (P) | 2014-05-04 | 2014-05-14 | FOXTROT TRIAL | N | N | 270019206 | CETUXIMAB + RT |
| 270009547 | 270005663 | 1.7 | null | Neo-adjuvant (N) | 2014-07-16 | 2014-07-26 | Carboplatin + Etoposide iv&po | 02 | Y | 270019211 | CARBOPLATIN |
| 270009548 | 270005663 | 1.66 | 86.5 | Neo-adjuvant (N) | 2014-03-31 | 2014-04-10 | Bevacizumab + Cape + Oxali 21day | Y | N | 270019211 | CETUXIMAB + IRINOTECAN |